Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this research is to determine if two proteins in the blood are increased during acute heart failure. These two proteins are produced when the heart becomes dysfunctional and unable to contract normally. They may then be released into the blood and be detected by standard method in the research laboratory. Thus, the purpose of this study is to determine the relation between the change of these two proteins in the blood and the occurrence of acute heart failure. At this time, detection of an increase in these proteins in the blood is not known to be associated with any disease or heart failure.
Sponsor: UConn Health
You may qualify if…
- ✓ Individuals aged \>18yrs
- ✓ stable or decompensated heart failure, irrespective of LVEF
- ✓ decompensated heart failure clinical symptoms such as dyspnea, rales, edema, elevated jugular venous pressure, or ascites
- ✓ Imaging evidence of heart failure (cardiomegaly, poor contractile function or echocardiographic Doppler evidence of diastolic dysfunction or elevated right- or left-sided filling pressures)
- ✓ Healthy individuals with no prior history of heart attack or heart failure will be recruited to use as controls.
You may not qualify if…
- ✕ Subjects who are unable to give informed consent
- ✕ Subjects who had undergone cardiac or non-cardiac surgery in the 3 months before enrollment
- ✕ Pregnant subjects are not excluded
Where it's recruiting
Farmington
Source: ClinicalTrials.gov · NCT00762008 · last updated 2025-08-12